Remove Bacterium Remove Gene Remove Generic Drugs Remove Generic Pharmaceutical
article thumbnail

Top 30 Pharma and Biotech Companies in 2023: Statistics and Trends

XTalks

But all three drugs have new competitors. Meanwhile, BioMarin’s gene therapy Roctavian is approved by the FDA for the treatment of hemophilia A. Additionally, Bayer has formed a partnership with Mammoth Biosciences to broaden its product portfolio with innovative gene-editing technology. Both are anti-CD20 agents.

Sales 98